Articles by Jennifer Markarian - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jennifer Markarian

Jennifer Markarian

FDA Takes Actions to Prevent Drug Shortages
November 1, 2013

FDA releases a strategic plan and issues a proposed notification rule to improve prevention and resolution of drug shortage problems.

Using Plastic for Parenteral Containers
June 1, 2013

A Q&A with SCHOTT Pharmaceutical Systems and West Pharmaceutical Services

Facility Trends: Modularization and Single Use
May 1, 2013

BioPharm International spoke with INTERPHEX 2013 conference-session presenters to gain insight on trends in facility and process design.

FDA Investigates Med Prep Consulting for Contaminated Intravenous Solution
March 21, 2013

The New Jersey-licensed specialty pharmacy recalls magnesium sulfate products and halts all production operations.

Daiichi Sankyo Condemns Falsely-represented Product
March 8, 2013

Product sold online in Malaysia and Indonesia infringes on the company’s trademark.

Report Explores Future of Opioid Abuse-Resistant Formulations
February 21, 2013

A GBI Research report says the opioid market will be driven by development of new products and post-marketing studies designed to reduce abuse risk.

GSK Announces Fourth Quarter 2012 Results and 2013 Plans
February 7, 2013

Group sales were down, but R&D progress points to future growth.

US Pharmacopeial Convention Announces Revised Official Dates for Elemental Impurities Chapters
January 31, 2013

Two general chapters on elemental impurities? limits and procedures are to become official Feb. 1, 2013, with implementation proposed for May 1, 2014.

Rutgers University Research Center and Janssen Develop Continuous Manufacturing Process
January 17, 2013

Rutgers engineers constructed a direct compaction line in collaboration with Janssen.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here